#33FUZKK atlas leaders 1–100

Serum Institute of India Pvt Ltd

Maharashtra · Maharashtra / Mumbai–Pune

Diversified pharmaBiologicsVaccines and biological products

Manufacturing profile

Diversified pharma
Biologics
Vaccines and biological products

State / territory: Maharashtra

Pharmaceutical cluster: Maharashtra / Mumbai–Pune

Selection basis

The company is placed in positions 1–100 as a major Indian manufacturer, exporter, API/CDMO, generics, vaccine or biopharma participant.

The Top 500 is a FUZKK atlas priority rather than a single official revenue table. Licence status, GMP status and the actual site portfolio must be rechecked through CDSCO and the relevant State Drug Controller.

Representative manufacturing and QC chain

  1. 1Portfolio of products and manufacturing sites
  2. 2Multiple manufacturing process types
  3. 3Shared supplier, validation and data controls
  4. 4Product-specific and instrumental QC
  5. 5Group QMS, release and lifecycle evidence
  6. 6Cell bank or microbial seed
  7. 7Upstream culture or fermentation
  8. 8Clarification and chromatography
  9. 9UF/DF, formulation and sterile filtration

Relevant FUZKK packages

Suggested first pilot

  1. Confirm one real product, method or recurring QC review.
  2. Record the instrument, export format and current specification.
  3. Select 3–7 utilities from the map above.
  4. Run a PASS/FAIL sample and agree the expected output.
  5. After user validation, expand to other products and sites.

Mapping boundary

The Top 500 is a FUZKK atlas priority rather than a single official revenue table. Licence status, GMP status and the actual site portfolio must be rechecked through CDSCO and the relevant State Drug Controller.

Methodology